Subscribe
Services & Experiences
10 min read

Joshua Fitzgerald | CEO, Zoomin Groomin

Joshua Fitzgerald lived Zoomin Groomin as a franchisee before running it. Now, past 300 mobile grooming vans, the CEO argues operational discipline beats flashy growth, walks through the metrics every franchisee should obsess over, and explains how the Loyalty Brands umbrella turns buying power and franchising experience into a competitive edge.

Written by
Roy Ben-Tzvi
Published on
October 27, 2026
Joshua Fitzgerald, CEO of Zoomin Groomin

When Joshua Fitzgerald became CEO of Zoomin Groomin, he wasn't stepping into an unfamiliar business - he had already lived it as a franchise owner. Before leading one of the fastest-growing mobile grooming brands in North America, he spent years hiring staff, optimizing routes, improving profitability, and solving the same day-to-day challenges franchisees face today.

Now, after surpassing 300 mobile grooming vans, Fitzgerald is focused on something many franchise systems struggle to achieve: scaling without sacrificing consistency. In this conversation, he explains why operational discipline beats flashy growth, the metrics every franchisee should obsess over, how Loyalty Brands gives Zoomin Groomin a competitive advantage, and why becoming the industry's clear market leader starts with helping franchisees build better businesses.

You went from franchisee to CEO in a remarkably short period of time. Looking back, what experiences as an owner prepared you most for leading the entire Zoomin Groomin operation today?

It happened fast, but I think the transition made sense because I had already been in it every day as a franchisee. Owning a market forces you to figure everything out, hiring, staffing, client retention, scheduling, profitability, and fixing problems as they happen. You learn quickly what actually moves the needle and what doesn’t.

That gave me a big advantage stepping into the CEO role because I’ve lived the same challenges our franchisees face. I know what it feels like to invest your own money, build a team, and carry the pressure of making it work. So when we make decisions at the corporate level, I’m always looking at it through that lens.

The biggest thing I learned as an owner is that small details matter. A few extra dollars on ticket average, one more groom a day, tighter routes, better hiring, those things seem small until you scale them across hundreds of vans. That’s where growth really happens.

At the end of the day, I think being an owner first gave me credibility. I’m not asking anyone to do something I haven’t done myself, and that matters.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Pro
Keep Reading

Other Interviews

More conversations with founders, operators, and investors building the future of pet care.

Learn more
Deven Vespi | Advisor, DRV Advisory
Pet Health & Wellness
13 min read

Deven Vespi | Advisor, DRV Advisory

Clinically proven has no shared definition in pet, yet it now shapes deals as much as labels. Deven Vespi learned the trade in FDA-regulated animal health, and she explains how to check a study before you trust it or build a deal on it. She covers sample sizes, dosing gaps, why brands get blindsided by their own research, and how long published data stays an edge.

Learn more
Learn more
Meet the Founders: 3 Startups Shaping the Future of Pet Health
Pet Health & Wellness
10 min read

Meet the Founders: 3 Startups Shaping the Future of Pet Health

Pawsible Ventures took seven of more than 130 applicants into its second cohort. Three of them work very different corners of pet health. Nicole Shlomof and Gila Leibovitch of Pawp Water sell functional water to owners who already fill the bowl, Andria Beal of EpiPaws turned dolphin epigenetics research into biological-age tests for dogs and cats, and Elliot Greenwood of ChckVet sells software to vet practices that resist new tech.

Learn more
Learn more
Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics
Pet Health & Wellness
17 min read

Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics

Elizabeth Iorns lost her French Bulldog to a brain tumor that a published canine study suggested could be treated, but no company had taken the drug forward for dogs. Now she and Science Exchange co-founder Dan Knox license the companion animal rights to human drugs at Familiar Therapeutics: 13 programs and $5 million raised in five months, plus a pitch to pharma that pet trials validate targets faster than phase two.

Learn more
View all interviews